CN114588108A - 含抗虫剂的油溶性溶液剂及其制备方法和应用 - Google Patents
含抗虫剂的油溶性溶液剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN114588108A CN114588108A CN202210365280.0A CN202210365280A CN114588108A CN 114588108 A CN114588108 A CN 114588108A CN 202210365280 A CN202210365280 A CN 202210365280A CN 114588108 A CN114588108 A CN 114588108A
- Authority
- CN
- China
- Prior art keywords
- oil
- insect
- soluble solution
- resistant agent
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000238631 Hexapoda Species 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 94
- 239000002904 solvent Substances 0.000 claims abstract description 71
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 33
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 claims abstract description 31
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 claims abstract description 29
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 29
- 239000003961 penetration enhancing agent Substances 0.000 claims abstract description 25
- 239000000077 insect repellent Substances 0.000 claims abstract description 23
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 11
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims description 76
- 235000019198 oils Nutrition 0.000 claims description 76
- 238000003756 stirring Methods 0.000 claims description 73
- 238000002156 mixing Methods 0.000 claims description 40
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 claims description 38
- 229960004816 moxidectin Drugs 0.000 claims description 37
- 235000006708 antioxidants Nutrition 0.000 claims description 28
- 239000000049 pigment Substances 0.000 claims description 27
- 238000001914 filtration Methods 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 14
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 claims description 13
- 229960003997 doramectin Drugs 0.000 claims description 13
- 241001465754 Metazoa Species 0.000 claims description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 8
- 229920002367 Polyisobutene Polymers 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- BVCOHOSEBKQIQD-UHFFFAOYSA-N 2-tert-butyl-6-methoxyphenol Chemical compound COC1=CC=CC(C(C)(C)C)=C1O BVCOHOSEBKQIQD-UHFFFAOYSA-N 0.000 claims description 5
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 5
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 claims description 5
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 5
- 239000005660 Abamectin Substances 0.000 claims description 5
- 229950008167 abamectin Drugs 0.000 claims description 5
- 229960002418 ivermectin Drugs 0.000 claims description 5
- 229940057917 medium chain triglycerides Drugs 0.000 claims description 5
- 208000030852 Parasitic disease Diseases 0.000 claims description 4
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 235000012343 cottonseed oil Nutrition 0.000 claims description 4
- 239000002385 cottonseed oil Substances 0.000 claims description 4
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 150000001746 carotenes Chemical class 0.000 claims description 3
- 235000005473 carotenes Nutrition 0.000 claims description 3
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 claims description 3
- CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 claims description 3
- 229940099245 milbemycin oxime Drugs 0.000 claims description 3
- -1 nonyl compound Chemical class 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims description 2
- XIEWGQFCESQNBK-UHFFFAOYSA-N 2-hexanoyloxyethyl hexanoate Chemical compound CCCCCC(=O)OCCOC(=O)CCCCC XIEWGQFCESQNBK-UHFFFAOYSA-N 0.000 claims description 2
- LSIDHXSWCFFFGE-UHFFFAOYSA-N 7-Methyloctyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCC(C)C LSIDHXSWCFFFGE-UHFFFAOYSA-N 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 2
- 240000007817 Olea europaea Species 0.000 claims description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 claims description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 2
- 229940093471 ethyl oleate Drugs 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000010388 propyl gallate Nutrition 0.000 claims description 2
- 239000000473 propyl gallate Substances 0.000 claims description 2
- 229940075579 propyl gallate Drugs 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 229960001777 castor oil Drugs 0.000 claims 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims 1
- 229920001748 polybutylene Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 239000000273 veterinary drug Substances 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 83
- 239000000047 product Substances 0.000 description 37
- 239000000203 mixture Substances 0.000 description 15
- 238000005070 sampling Methods 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 14
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 14
- 238000002372 labelling Methods 0.000 description 14
- 239000004540 pour-on Substances 0.000 description 13
- 238000007789 sealing Methods 0.000 description 13
- 239000011265 semifinished product Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000011049 filling Methods 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 229920001083 polybutene Polymers 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 241000238876 Acari Species 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 241000238421 Arthropoda Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 229940000188 cydectin Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
成分 | 物料 | 用量 |
抗虫剂 | 多拉菌素 | 2.5% |
抗氧化剂 | 三乙醇胺 | 0.125% |
促渗剂 | 肉豆蔻酸异丙酯/氮酮 | 10%/5% |
成膜剂 | 聚异丁烯 | 25% |
色素 | 油溶胡萝卜素 | 0.03% |
油溶剂 | 丙二醇二辛酸酯/二癸酸酯 | 余量 |
成分 | 物料 | 用量 |
抗虫剂 | 莫昔克丁 | 0.5% |
抗氧化剂 | 叔丁基羟基茴香醚 | 0.05% |
促渗剂 | 肉豆蔻酸异丙酯 | 10% |
色素 | 油溶紫 | 0.03% |
油溶剂 | 中链甘油三酯 | 余量 |
成分 | 物料 | 用量 |
抗虫剂 | 莫昔克丁 | 0.5% |
抗氧化剂 | 叔丁基羟基茴香醚 | 0.05% |
促渗剂 | 肉豆蔻酸异丙酯 | 10% |
色素 | 油溶紫 | 0.03% |
油溶剂 | 丙二醇二辛酸酯/二癸酸酯 | 余量 |
成分 | 物料 | 用量 |
抗虫剂 | 莫昔克丁 | 0.5% |
抗氧化剂 | 叔丁基羟基茴香醚 | 0.05% |
促渗剂 | 肉豆蔻酸异丙酯/棕榈酸异丙酯 | 10%/5% |
色素 | 油溶紫 | 0.03% |
油溶剂 | 中链甘油三酯 | 余量 |
取样时间 | -20℃ | -8℃ | 0℃ | 2-8℃ | 25℃ | 40℃ | 60℃ |
对比例1 | 凝固 | 129.3 | 100.1 | 63.8 | 35.8 | 26.2 | 10.3 |
实施例2 | 130.5 | 110.4 | 74.3 | 63.4 | 34.9 | 23.2 | 10.1 |
实施例3 | 129.3 | 109.2 | 72.2 | 63.4 | 34.9 | 23.2 | 10.1 |
实施例4 | 128.1 | 105.2 | 70.4 | 62.5 | 33.5 | 22.6 | 10.0 |
实施例5 | 125.3 | 104.6 | 69.9 | 60.8 | 32.5 | 21.3 | 9.9 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210365280.0A CN114588108B (zh) | 2022-04-07 | 2022-04-07 | 含抗虫剂的油溶性溶液剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210365280.0A CN114588108B (zh) | 2022-04-07 | 2022-04-07 | 含抗虫剂的油溶性溶液剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114588108A true CN114588108A (zh) | 2022-06-07 |
CN114588108B CN114588108B (zh) | 2024-04-19 |
Family
ID=81813374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210365280.0A Active CN114588108B (zh) | 2022-04-07 | 2022-04-07 | 含抗虫剂的油溶性溶液剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114588108B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024124471A1 (zh) * | 2022-12-15 | 2024-06-20 | 科笛生物医药(无锡)有限公司 | 羟基二苯乙烷类化合物软膏及其用途和制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102133173A (zh) * | 2011-03-03 | 2011-07-27 | 浙江海正药业股份有限公司 | 一种莫西克汀浇泼剂及其制备方法 |
WO2012085160A1 (en) * | 2010-12-21 | 2012-06-28 | Norbrook Laboratories Limited | Formulations of antiparasitic agents for topical administration to swine |
CN104739753A (zh) * | 2015-03-04 | 2015-07-01 | 内蒙古金河动物药业有限公司 | 一种稳定的油性伊维菌素浇泼剂及其制备方法 |
CN113557015A (zh) * | 2018-12-21 | 2021-10-26 | 礼蓝美国公司 | 杀寄生虫制剂及其用途 |
CN114259464A (zh) * | 2021-11-25 | 2022-04-01 | 吉林大学 | 一种复方莫昔克丁外用滴剂 |
-
2022
- 2022-04-07 CN CN202210365280.0A patent/CN114588108B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012085160A1 (en) * | 2010-12-21 | 2012-06-28 | Norbrook Laboratories Limited | Formulations of antiparasitic agents for topical administration to swine |
CN102133173A (zh) * | 2011-03-03 | 2011-07-27 | 浙江海正药业股份有限公司 | 一种莫西克汀浇泼剂及其制备方法 |
CN104739753A (zh) * | 2015-03-04 | 2015-07-01 | 内蒙古金河动物药业有限公司 | 一种稳定的油性伊维菌素浇泼剂及其制备方法 |
CN113557015A (zh) * | 2018-12-21 | 2021-10-26 | 礼蓝美国公司 | 杀寄生虫制剂及其用途 |
CN114259464A (zh) * | 2021-11-25 | 2022-04-01 | 吉林大学 | 一种复方莫昔克丁外用滴剂 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024124471A1 (zh) * | 2022-12-15 | 2024-06-20 | 科笛生物医药(无锡)有限公司 | 羟基二苯乙烷类化合物软膏及其用途和制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114588108B (zh) | 2024-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1081030C (zh) | 含有曲尼司特的外用制剂及其制备方法 | |
CN1042394C (zh) | 表面使用的药物组合物的制备方法 | |
CN106074453B (zh) | 高乌甲素凝胶贴膏及其制备方法 | |
CN106474120A (zh) | 包含异噁唑啉活性剂的杀寄生物组合物,其方法和用途 | |
AU2010242415A1 (en) | Flexible liposome of resveratrol and preparation method thereof | |
CN107028919A (zh) | 一种复方七叶皂苷a、b脂质体水凝胶贴剂 | |
CN110946846B (zh) | 一种不含透皮促渗剂的洛索洛芬钠凝胶膏基质及其制备方法 | |
CN107550775A (zh) | 天然植物祛痘啫喱及其制备方法 | |
CN114588108A (zh) | 含抗虫剂的油溶性溶液剂及其制备方法和应用 | |
CN114980890A (zh) | 可注射长效镇痛药物组合物及其制备方法和用途 | |
CN102379862B (zh) | 一种含有水杨酸羟乙酯的亲水性巴布剂 | |
CN109843282A (zh) | 水性贴剂 | |
JP5073124B2 (ja) | ノルアドレナリン作動性・特異的セロトニン作動性抗うつ薬含有経皮吸収型貼付製剤 | |
CN102657602A (zh) | 3,5-二羟基-4-异丙基二苯乙烯壳聚糖凝胶剂及其制备方法 | |
CN110022864A (zh) | 用于治疗睡眠障碍的经皮吸收制剂 | |
WO2009007334A2 (de) | Transdermale therapeutische systeme, welche den wirkstoff anastrozol enthalten | |
CN103211758A (zh) | 一种液晶纳米粒透皮剂及其制备方法 | |
ES2394313T3 (es) | Formulación transdérmica que comprende un analgésico opioide y una composición de aloe | |
CN100394983C (zh) | 含有大豆油的多拉菌素注射液 | |
CN102283807B (zh) | 液态前体脂质体的制备方法和应用方法 | |
CN108685879A (zh) | 一种卡巴拉汀透皮贴及其制备方法 | |
CN103908463A (zh) | 一种林可霉素利多卡因凝胶剂及其制备工艺 | |
Yadav et al. | FORMULATION AND EVALUATION ANTI-INFLAMMATORY GEL OF SARCOSTEMMA ACIDUM | |
US5543432A (en) | Application of trace elements to animals | |
CN107252431A (zh) | 一种复方七叶皂苷a脂质体水凝胶贴剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240325 Address after: No. 8 Shilong Avenue, Xinji Village Committee, Shijiao Town, Qingcheng District, Qingyuan City, Guangdong Province 511545. Lizhu Group Xinbeijiang Pharmaceutical Co., Ltd. has built Workshop 201 (third floor) and Workshop 202 (fourth floor) for animal protection Applicant after: Lijian (Guangdong) Animal Health Co.,Ltd. Country or region after: China Address before: 511518 Renmin 1st Road, Qingyuan City, Guangdong Province Applicant before: LIVZON NEW NORTH RIVER PHARMACEUTICAL Co.,Ltd. Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |